智通财经网·2025-09-01 10:21Core Viewpoint - The announcement details a share reduction plan by the former vice chairman of Zhaoyan New Drug, indicating a potential shift in shareholder sentiment and possible implications for the company's stock performance [1] Summary by Relevant Sections Share Reduction Plan - The former vice chairman, Zuo Conglin, disclosed a share reduction plan on August 14, 2025, intending to reduce holdings between August 19 and August 29, 2025 [1] - The plan allows for a maximum reduction of 3.5245 million shares, which represents up to 0.4703% of the company's total share capital at that time [1] Execution of the Plan - By the end of the reduction period on August 29, 2025, Zuo Conglin had reduced his holdings by 2.2649 million shares through centralized bidding [1]